A Genotype-guided Phase I Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 May 2017
At a glance
- Drugs Bevacizumab (Primary) ; Irinotecan (Primary) ; Fluorouracil; Folic acid; Folinic acid
- Indications Colorectal cancer
- Focus Adverse reactions
- 22 May 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 22 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 09 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Apr 2017.